In today’s episode, I breakdown the ICPT NASH results, followed up by a quick take on SAGE and the latest buyout rumors.

*this is not investment advice*

Relevant links:
http://ir.interceptpharma.com/news-releases/news-release-details/intercept-announces-positive-topline-results-pivotal-phase-3
https://www.sagerx.com/

http://www.breakingbiotech.com